Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Open-market sale Chief Development Officer sold 3,000 shares at $4.63 ($13,888)
  2. 4 Open-market sale Chief Commercial Officer sold 5,586 shares at $3.00 ($16,764)
  3. 4 Open-market sale Chief Medical Officer sold 3,187 shares at $3.00 ($9,564)
  4. 4 Open-market sale Blanks Robert sold 3,394 shares at $3.00 ($10,185)
  5. 4 Open-market sale GRAMMER ELIZABETH A sold 2,914 shares at $3.00 ($8,745)
  6. 4 Open-market sale President & CEO sold 13,449 shares at $3.00 ($40,360)
  7. 4 Open-market sale Felsch Robert Ora sold 3,214 shares at $3.00 ($9,645)
  8. 4 Open-market sale Chief Financial Officer sold 3,439 shares at $3.00 ($10,320)
  9. 4 Open-market sale Chief Development Officer sold 4,508 shares at $3.00 ($13,529)
  10. 4 Grant or award Chief Development Officer acquired 103,325 shares (grant or award)
  11. 4 Grant or award Felsch Robert Ora acquired 26,000 shares (grant or award)
  12. 4 Grant or award Blanks Robert acquired 78,000 shares (grant or award)
  13. 4 Grant or award GRAMMER ELIZABETH A acquired 78,000 shares (grant or award)
  14. 4 Grant or award Chief Financial Officer acquired 78,000 shares (grant or award)
  15. 4 Grant or award Chief Commercial Officer acquired 78,000 shares (grant or award)
  16. 4 Grant or award Chief Medical Officer acquired 78,000 shares (grant or award)
  17. 4 Grant or award President & CEO acquired 250,000 shares (grant or award)
  18. 4 Open-market sale Chief Development Officer sold 1,948 shares at an average $1.95 ($3,797)
  19. 4 Open-market sale GRAMMER ELIZABETH A sold 1,242 shares at an average $1.95 ($2,421)
  20. 4 Open-market sale Chief Commercial Officer sold 3,456 shares at an average $1.95 ($6,736)

Page 13 of 35 · 696 filings